Pablo G. Longo - Concepedia

Concepedia

Author

Pablo G. Longo

International Centre for Genetic Engineering and Biotechnology

Also Known As

P G Longo, P LONGO, P Longo, P. Longo, Pablo G Longo, Pablo G Longo MD, Pablo G. Longo, Pablo Longo

34

Publications

1.2K

Citations

11

H-Index

19

Concepts

All Affiliations

International Centre for Genetic Engineering and Biotechnology Agostino Gemelli University Polyclinic Catholic University of America European Molecular Biology Laboratory Università Cattolica del Sacro Cuore

PG

About

Pablo G. Longo is an author at International Centre for Genetic Engineering and Biotechnology specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	440
2	Cell Biology	4	4	408
3	Immunology	3	3	363
4	Orthopaedics	1	1	32
5	Pharmacology	1	1	32

Pablo G. Longo

×

10

Publications

1.2K

Citations

10

H-Index

	Year	Citations
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells Pablo G. Longo, Luca Laurenti, Stefania Gobessi, Blood	2007	314
Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells Stefania Gobessi, Luca Laurenti, Pablo G. Longo, Leukemia Hematological MalignancyInduces ApoptosisApoptosisImmunologyCell Death	2008	195
ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells Stefania Gobessi, Luca Laurenti, Pablo G. Longo, Blood	2006	169
The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling Mirza Suljagić, Pablo G. Longo, Sara Bennardo, Blood	2010	142
The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease Pablo G. Longo, Luca Laurenti, Stefania Gobessi, Leukemia Hematological MalignancyStable DiseaseLymphoid NeoplasiaMedicineMixed-phenotype Acute Leukemia	2006	140
Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT Roberto Negro, Stefania Gobessi, Pablo G. Longo, Blood	2012	79
Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation Laura Carsetti, Luca Laurenti, Stefania Gobessi, Cellular Signalling Signal TransductionSignaling PathwayCell DivisionActivation Loop TyrosinesCell Regulation	2009	45
Characteristics and Clinical Implications of the Pharmacokinetic Profile of Ibuprofen in Patients with Knee Osteoarthritis Luca Gallelli, Olimpio Galasso, A. Urzino, Clinical Drug Investigation Clinical ImplicationsAnti-inflammatoryPharmacokinetic ProfileMedicineChronic Musculoskeletal Condition	2012	32
The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia Michela Tarnani, Luca Laurenti, Pablo G. Longo, Leukemia Research Hematological MalignancyChronic Lymphocytic LeukemiaMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2010	28
Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: A multicenter experience from Argentina Ana Lisa Basquiera, Silvia Mariana Pizzi, Agustín González Correas, Pediatric Blood & Cancer	2014	16

Page 1